Published 2 years ago • loading... • Updated 2 years agoShow Less IconIt's the first drug shown to slow Alzheimer's. Why is is it off to a slow start? Summary by The Billings GazetteMore than 6 million Americans, and millions more worldwide, have Alzheimer’s disease, the most common cause of dementia. There’s no cure, but Leqembi clears a sticky brain protein called amyloid that’s a key indicator of Alzheimer’s.Share menu8 Articles8 ArticlesAllLeft1Center7RightSearch IconSort IconHelena Independent RecordThe Billings GazetteCenterView articleCaret Right IconMissoulianCenterView articleCaret Right IconNews & RecordLean LeftView articleCaret Right IconMontana StandardCenterView articleCaret Right IconOmaha World-HeraldCenterView articleCaret Right IconRapid City Journal Media GroupCenterView articleCaret Right IconDanville Register & BeeCenterView articleCaret Right Icon+7 Reposted by 7 other sourcesCenterFactualityOwnershipIt's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?More than 6 million Americans, and millions more worldwide, have Alzheimer’s disease, the most common cause of dementia. There’s no cure, but Leqembi clears a sticky brain protein called amyloid that’s a key indicator of Alzheimer’s.2 years ago·Helena, United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeCoverage DetailsTotal News Sources8Leaning Left1Leaning Right0Center7Last Updated2 years agoBias Distribution87% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon87% of the sources are Center87% Center13%C 87%+2Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageThe Billings Gazette broke the news in Billings, United States 2 years ago on Wednesday, April 17, 2024.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsAlzheimer's Disease Plus IconShow AllSimilar News TopicsAlzheimer's Disease Plus IconShow All